Tuberculosis service disruptions and adaptations during the first year of the COVID-19 pandemic in the private health sector of two urban settings in Nigeria—A mixed methods study
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Nigeria has the second largest share of undiagnosed TB cases in the world and a large private health sector estimated to be the point of initial care-seeking for 67% of TB patients. There is evidence that COVID-19 restrictions disrupted private healthcare provision, but insufficient data on how private healthcare provision changed as a result of the pandemic. We conducted qualitative interviews and a survey to assess the impact of the pandemic, and government response on private healthcare provision, and the disruptions providers experienced, particularly for TB services. Using mixed methods, we targeted policymakers, and a network of clinical facilities, laboratories, community pharmacies, and medicine vendors in Kano and Lagos, Nigeria. We interviewed 11 policymakers, surveyed participants in 2,412 private facilities. Most (n = 1,676, 70%) facilities remained open during the initial lockdown period, and most (n = 1,667, 69%) offered TB screening. TB notifications dipped during the lockdown periods but quickly recovered. Clinical facilities reported disruptions in availability of medical supplies, staff, required renovations, patient volume and income. Few private providers (n = 119, 11% in Kano; n = 323, 25% in Lagos) offered any COVID-19 screening up to the time of the survey, as these were only available in designated facilities. These findings aligned with the interviews as policymakers reported a gradual return to pre-COVID services after initial disruptions and diversion of resources to the pandemic response. Our results show that COVID-19 and control measures had a temporary impact on private sector TB care. Although some facilities saw decreases in TB notifications, private facilities continued to provide care for individuals with TB who otherwise might have been unable to seek care in the public sector. Our findings highlight resilience in the private sector as they recovered fairly quickly from pandemic-related disruptions, and the important role private providers can play in supporting TB control efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“this timeframe might have also provided opportunities for tuberculosis service recovery programmes87, 88, 89, 90 to mobilise and avert mortality.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
The Lancet Commission on diagnostics: transforming access to diagnostics
Fleming, K. A., Horton, S., Wilson, M. L., Atun, R., DeStigter, K., Flanigan, J., Sayed, S., Adam, P., Aguilar, B., Andronikou, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00673-5 · Cited by 471
Self-citationCovid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery
Pai, M., Kasaeva, T., & Swaminathan, S. (2022) · New England Journal of Medicine · doi:10.1056/nejmp2118145 · Cited by 236 · cited 1×
“The combination of non-pharmaceutical interventions such as lockdowns and the shifting of resources to COVID-19 has contributed to a sharp decline globally of 18% in the number of diagnosed TB cases in 2020 compared to 2019 [4,5].”
ResultSelf-citationCOVID-19 and Nigeria: putting the realities in context
Ohia, C., Bakarey, A. S., & Ahmad, T. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.04.062 · Cited by 156 · cited 1×
“As of December 2022, there were over 266,000 confirmed COVID-19 cases and 3,000 COVID-related deaths in Nigeria [18], although these numbers were likely underestimated [19].”
BackgroundTuberculosis in times of COVID-19
Zimmer, A., Klinton, J. S., Omenka, C. O., Heitkamp, P., Nyirenda, C. N., Furin, J. J., & Pai, M. (2021) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2021-217529 · Cited by 156 · cited 3×
“Several studies have highlighted the potential telemedicine offers in increasing healthcare access in low and middle income countries, particularly since the onset of the pandemic [34,35], even though its usage might be more suited to high-income settings with adequate access to smart phones, internet connectivity and…”
BackgroundResultSelf-citationNigeria’s public health response to the COVID-19 pandemic: January to May 2020
Dan-Nwafor, C., Ochu, C. L., Elimian, K., Oladejo, J., Ilori, E. A., Umeokonkwo, C. D., Steinhardt, L. C., Igumbor, E. U., Wagai, J. N., Okwor, T. J., et al. (2020) · Journal of Global Health · doi:10.7189/jogh.10.020399 · Cited by 149
Khan, M. S., Rego, S., Rajal, J. B., Bond, V. A., Fatima, R., Isani, A. K., Sutherland, J. S., & Kranzer, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244936 · Cited by 95 · cited 1×
“Several studies have highlighted the potential telemedicine offers in increasing healthcare access in low and middle income countries, particularly since the onset of the pandemic [34,35], even though its usage might be more suited to high-income settings with adequate access to smart phones, internet connectivity and…”
BackgroundNational policy on population for sustainable development
Nigéria (2004) · Medical Entomology and Zoology · Cited by 91
Williams, O. D., Yung, K.-C., & Grépin, K. A. (2021) · Global Public Health · doi:10.1080/17441692.2021.1874470 · Cited by 75
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria
Adewole, O. (2020) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.20.0418 · Cited by 71 · cited 1×
“COVID-19 infection control measures were implemented early in the pandemic to reduce infection and disease transmission; however, earlier reports indicated that they also led to challenges in accessing health services, especially for already vulnerable populations such as individuals with TB in Nigeria [6,14,15], as t…”
Result
Research works printed but not linked: 14
- World Health Organization, 2020, Global tuberculosis report, 2020
- World Health Organization, 2021, Global tuberculosis report 2021
- World Health Organization, 2021, Impact of the COVID-19 pandemic on TB detection and mortality in 2020
- World Health Organization, 2019, Global tuberculosis report 2019
- D Montagu, 2020, Private Sector Utilization: Insights from Standard Survey Data, Private Sector Landscape in Mixed Health Systems, 10
- World Health Organization, 2021, Engaging private health care providers in TB care and prevention: a landscape analysis
- World Health Organization, 2019, Multisectoral accountability framework to accelerate progress to end tuberculosis by 2030
- Johns Hopkins University, 2022, Coronavirus Resource Center—Nigeria
- G. Anyanwu, 2020, COVID-19: All Eligible Public, Private Hospitals Nationwide to Become Sample Collection Sites—Dr, Ehanire
- World Health Organization, 2021, Nigeria records gain in fight against tuberculosis amidst coronavirus pandemic
- National Bureau of Statistics, 2020, Demographic Statistics Bulletin
- AU Nyaruhirira, 2022, COVID-19 Diagnosis in Low-and Middle-Income Countries: the big new bully disrupting TB and HIV diagnostic services, The Journal of Molecular Diagnostics
- C Oga-Omenka, 2021, Healthcare
- Federal Ministry of Health. National Policy on Public-Private Partnership for Health in Nigeria. National Consultation Workshop on Public-Private Partnership in Nigeria 2005.
Cited by
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00007-0 · Cited by 146
COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
Cioboată, R., Biciuşcă, V., Olteanu, M., & Vasile, C. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144784 · Cited by 71
Impact of COVID-19 on the neglected tropical diseases: a scoping review
Butala, C. B., Cave, R. N. R., Fyfe, J., Coleman, P. G., Yang, G.-J., & Welburn, S. C. (2024) · Infectious Diseases of Poverty · doi:10.1186/s40249-024-01223-2 · Cited by 50
“TB clinics had to close due to lockdowns in several endemic countries, this delayed treatment of people willing and able to receive treatment, contributing to more transmission, reactivation of TB in patients, longer time of treatment and further TB complications [58, 59].”
BackgroundThe global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020–2023
Marco, M. H., Ahmedov, S., & Castro, K. G. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003043 · Cited by 37
Ledesma, J. R., Basting, A. V. L., Chu, H. T., Ma, J., Zhang, M., Vongpradith, A., Novotney, A., Dalos, J., Zheng, P., Murray, C. J. L., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11092191 · Cited by 20
“Nigeria collaborated early in the pandemic with the private sector, allowing private facilities to uninterruptedly provide care for individuals with TB who were otherwise unable to seek care in the public sector [66].”
Individual journeys to tuberculosis care in Nigeria’s private sector during the COVID-19 pandemic
Omenka, C. O., Rosapep, L., Baruwa, E. M., Huria, L., Vasquez, N. A., Olusola-Faleye, B., Kafi, M. A. H., Sassi, A., Nwosu, C., Johns, B., et al. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2023-013124 · Cited by 14
Self-citationSassi, A., Lestari, B. W., Muna, K. U. N. E., Omenka, C. O., Afifah, N., Widarna, R., Huria, L., Vasquez, N. A., Benedetti, A., Hadisoemarto, P. F., et al. (2024) · BMC Public Health · doi:10.1186/s12889-023-17001-y · Cited by 14
“Few studies to date have investigated how the quality of TB services was impacted by the COVID-19 pandemic [24–26].”
BackgroundSelf-citationLeveraging Global Fund’s investments to expand innovative public-private provider engagement in TB
Yassin, M. A., Kimbo, L., Wandwalo, E. R., Rashid, A., Dzokoto, A., Weber, U., & Stallworthy, G. (2024) · IJTLD OPEN · doi:10.5588/ijtldopen.24.0162 · Cited by 12
Tuberculosis Trends in the Post‐COVID‐19 Era: Is It Going to be a Global Concern?
Khojasteh‐Kaffash, S., Habibzadeh, A., Moghaddam, S., Afra, F., Samieefar, N., & Fateh, A. (2025) · Health Science Reports · doi:10.1002/hsr2.70792 · Cited by 16
“Strict quarantine measures aimed at controlling the spread of the COVID ‐ 19 and caused disruptions to the regular provision and screening of TB services, including those with high rates of TB, particularly during the first wave of the pandemic [119, 120].”
Brubacher, L. J., Yellappa, V., Lestari, B. W., Heitkamp, P., Vasquez, N. A., Sassi, A., Olusola-Faleye, B., Thapa, P., Klinton, J. S., Sheokand, S., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-016180 · Cited by 13
“16 18 While our findings reveal differing pandemic control and preparedness strategies to varying degrees across countries, we found three major themes across the three countries.”
Self-citationVasquez, N. A., Omenka, C. O., Yellappa, V., Lestari, B. W., Sassi, A., Sheokand, S., Olusola-Faleye, B., Huria, L., Brubacher, L. J., Baruwa, E. M., et al. (2024) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2024.100503 · Cited by 9
Self-citationIfeanyi, O., Ojeh, O., Okoineme, K., Adizue, J. C., Wada, Y. H., Adeyemo, E., Anyanti, J., Yola, A. M., & Umar, A. S. (2024) · International Journal of Public Health · doi:10.3389/ijph.2024.1606807 · Cited by 4
Leveraging tuberculosis programs for future pandemic preparedness: A retrospective look on COVID-19
Bowen, W., Ho, T., Romero, S., Shaheen, R., Kipngetich, V., McGowan, N., Moon, S., Bhattacharya, E., Hecht, R., Soe-Lin, S., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003454 · Cited by 4
Sassi, A., Rosapep, L., Olusola-Faleye, B., Baruwa, E. M., Johns, B., Kafi, M. A. H., Huria, L., Vasquez, N. A., Daniels, B., Das, J., et al. (2024) · BMJ Global Health · doi:10.1136/bmjgh-2024-015474 · Cited by 2
“However, as the associations found between correct management and a term combining provider gender and SP gender in the 2019 SP study were largely determined by provider gender, we opted to include just provider gender in our model to account for most of this variation.”
Self-citationPamba, D. I., Sanga, E., William, W., Mvungi, H., Kigumi, H. O., Setebe, T., Olomi, W., Mangu, C., Sabi, I., Balama, R., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094564 · Cited by 3
“Doreen Pamba http://orcid.org/0000-0002-6822-5682 Erica Samson Sanga http://orcid.org/0000-0002-1764-545X”
Deprioritized and disrupted: tuberculosis care in the shadow of COVID-19
Sharma, S. K. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1651902 · Cited by 2
Kafi, M. A. H., Thapa, P., Pai, M., & Omenka, C. O. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0007214 · Cited by 2
“This sample size was determined to be logistically feasible for intensive, in-person patient journey mapping while providing sufficient descriptive data to compare healthcare-seeking patterns across the two contrasting urban settings of Mumbai and Patna.”
Self-citationDinh, L. V., Vo, L. N. Q., Wiemers, A. M. C., Nguyen, H. B., Vu, H. Q., Mo, H. T. L., Nguyen, L. P., Nguyen, N. T. T., Dong, T. T. T., Tran, K. T., et al. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9010026 · Cited by 3
“However, the aftermath of the aforementioned public health response to COVID-19 and deleterious impact on the country’s TB care and prevention system was less overt, thus necessitating further response to the initial public health response [16,17].”
BackgroundMitchell, E. M. H., Adejumo, O. A., Abdur-Razzaq, H., Ogbudebe, C. L., & Gidado, M. (2024) · JMIR Public Health and Surveillance · doi:10.2196/52191 · Cited by 2
“The globally networked, economically and culturally dynamic hub of Lagos, Nigeria, has long been identified as a place where timely information on emerging pathogens, pharmacovigilance, and infectious disease surveillance is crucial to the country’s public health [4].”
Widarna, R., Afifah, N., Djunaedy, H. A. K., Sassi, A., Vasquez, N. A., Omenka, C. O., Salindri, A. D., Lestari, B. W., Pai, M., & Alisjahbana, B. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003112 · Cited by 2
Self-citationOkethwangu, D., Johansen, M., Ahirirwe, S., Venkateswaran, M., Mayega, R., Rutebemberwa, E., Ocom, F., Nankabirwa, V., Okot, C. L., Nyachwo, E. B., et al. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0006938 · Cited by 1
Syamsir, S. B., Permatasari, H., & Setiawan, A. (2023) · PubMed Central · doi:10.30476/ijcbnm.2023.98768.2257 · Cited by 2
“27, 28 As a result, the increased prevalence of COVID-19 has significantly reduced hospital admissions and referrals.”
BackgroundSassi, A., Rosapep, L., Olusola-Faleye, B., Baruwa, E. M., Johns, B., Kafi, M. A. H., Huria, L., Vasquez, N. A., Daniels, B., Das, J., et al. (2024) · medRxiv · doi:10.1101/2024.02.17.24302708
Self-citationThe Relationship between Tuberculosis and Corona Virus
Shareef, S. A., Aldulaimy, M. K., & Mohammed, W. A. (2024) · Stallion Journal for Multidisciplinary Associated Research Studies · doi:10.55544/sjmars.3.5.4
KEY DRIVERS OF HIGH TB BURDEN IN TOP 10 COUNTRIES: A SYSTEMATIC REVIEW
Thin, N. T., Hlaing, T., & Soe, P. P. (2025) · Health Informatics - An International Journal · doi:10.5121/hiij.2025.14301
Additional file 1 of Impact of COVID-19 on the neglected tropical diseases: a scoping review
Butala, C. B., Cave, R. N. R., Fyfe, J., Coleman, P. G., Yang, G.-J., & Welburn, S. C. (2024) · Figshare · doi:10.6084/m9.figshare.26401940
Sassi, A., Lestari, B. W., El Muna, K. U. N., Omenka, C. O., Afifah, N., Widarna, R., Huria, L., Vasquez, N. A., Benedetti, A., Hadisoemarto, P. F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24953121
Self-citationAdditional file 2 of Impact of COVID-19 on the neglected tropical diseases: a scoping review
Butala, C. B., Cave, R. N. R., Fyfe, J., Coleman, P. G., Yang, G.-J., & Welburn, S. C. (2024) · Figshare · doi:10.6084/m9.figshare.26401985
Tuberculosis outcomes during the COVID-19 pandemic in two high-burden countries
Faust, L. (2023) · eScholarship@McGill (McGill) · doi:10.82308/9613
Aurora, W. I. D., Maharani, Ekaputri, T. W., Darmawan, A., Kusdiyah, E., & Sulistiawan, A. (2026) · JURNAL KESEHATAN LINGKUNGAN · doi:10.20473/jkl.v18i2.2026.93-100
“These socio-economic disparities have also contributed to public health, suggesting that integrated public health planning is essential (32,40–42).”
Mike-Ogburia, M. I., Precious, D. F., Alozie, F. C., Ofurum, F. C., Israel, D. E., & Bekee, D. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13731-7
“In Nigeria, the pandemic also disrupted TB service delivery, including within the private health sector, although adaptive responses were later reported [4, 13].”
Aighobahi, J. O., & Mac, P. A. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.109126
Metadata
- Authors
- Oga-Omenka, C., Sassi, A., Vasquez, N. A., Baruwa, E., Rosapep, L., Daniels, B., Olusola-Faleye, B., Huria, L., Adamu, A., Johns, B., Das, J., & Pai, M.
- Affiliations
- McGill University (CA)
- Abt Global (United States) (US)
- Georgetown University (US)
- Corresponding author
- Sassi, Angelina
- Vasquez, Nathaly Aguilera
- Baruwa, Elaine
- Rosapep, Lauren
- Daniels, Benjamin
- Olusola-Faleye, Bolanle
- Huria, Lavanya
- Adamu, Abdu
- Johns, Benjamin
- Das, Jishnu
- Pai, Madhukar
- ORCID
- Venue
- PLOS Global Public Health
- Publisher
- Public Library of Science (PLoS)
- Published
- 2023-03-24
- Volume
- 3
- Issue
- 3
- Pages
- e0001618
- ISSN
- 2767-3375 (ISSN-L)
- PMC
- PMC10038269
- OpenAlex
- W4360839090
- Cited by
- 32
- References
- 30
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 19 · 2023: 5
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLOS Global Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bill and Melinda Gates Foundation (INV-022420)
- SHOPS Plus Project in Nigeria (AID-OAA-A-15- 00067)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Keywords
- tuberculosis, COVID-19 pandemic, private health sector, healthcare disruption, tuberculosis screening, tuberculosis notification, lockdown, medical supply shortages, private providers, tuberculosis control, Nigeria, Kano, Lagos
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.